Nanobiotix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. 

CEO
Laurent Lévy
CEOLaurent Lévy
Employees
108
Employees108
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
2003
Founded2003
Employees
108
Employees108

NBTX Key Statistics

Market cap
787.82M
Market cap787.82M
Price-Earnings ratio
-18.13
Price-Earnings ratio-18.13
Dividend yield
Dividend yield
Average volume
104.45K
Average volume104.45K
High today
$16.98
High today$16.98
Low today
$14.00
Low today$14.00
Open price
$14.46
Open price$14.46
Volume
129.92K
Volume129.92K
52 Week high
$16.98
52 Week high$16.98
52 Week low
$2.76
52 Week low$2.76

NBTX News

TipRanks 5d
Nanobiotix price target raised to EUR 13 from EUR 10 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Nanobiotix (NBTX) to EUR 13 from EUR 10 and keeps a Buy rating on the shares. The company announced positive r...

Benzinga 6d
Melanoma Data Study Boosts J&J Partner Nanobiotix Stock On Thursday

Nanobiotix SA NBTX announced new results focused on patients with primary cutaneous melanoma from an ongoing Phase 1 Study. 1100 evaluating JNJ-1900 (NBTXR3) i...

Melanoma Data Study Boosts J&J Partner Nanobiotix Stock On Thursday
Benzinga 6d
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday

U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points on Thursday. Shares of Radian Group Inc. RDN rose sharply during Thursday's ses...

Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

More NBTX News

Seeking Alpha 7d
Nanobiotix soars on positive phase 1 results for JNJ-1900 in melanoma

Nanobiotix (NASDAQ:NBTX) shares rose sharply in Thursday's premarket trading after the company announced new Phase 1 study results for JNJ-1900 in melanoma. Th...

Nanobiotix soars on positive phase 1 results for JNJ-1900 in melanoma
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.